<DOC>
	<DOCNO>NCT02676674</DOCNO>
	<brief_summary>This pre-post open label trial ass change Vitamin D blood level follow treatment three dose topical Vitamin D3 20 subject exist Vitamin D deficiency .</brief_summary>
	<brief_title>Vitamin D Levels Following Topical Application Vitamin D Ointment</brief_title>
	<detailed_description>The propose study investigate safety efficacy new topical vitamin D3 compound . The purpose Phase 1 trial determine whether topical application make Vitamin D bioavailable systemic circulation sufficient quantity treat hypovitaminosis D. The study assess change serum 25-hydroxy ( 25-OH ) vitamin D concentration follow 3 dos 100,000 IU topical vitamin D3 ointment 20 volunteer vitamin D deficiency . Twenty adult serum 25-OH vitamin D concentration &lt; 20 ng/ml receive 3 dos 300,000 IU topical vitamin D per week three week . Two 0.75 ml applicator ointment apply upper arm ( 150,000 IU per arm ) study staff . Blood drawn baseline prior first dose ( Day 0 ) Days 7 , 14 , 21 . Total serum 25-OH vitamin D assay draw . Parathyroid hormone , measure clinical effect low vitamin D level , check baseline day 21 . Serum albumin adjust calcium level check draw check possible effect much vitamin D absorption . The study determine whether topical application Vitamin D ointment able correct exist vitamin D deficiency .</detailed_description>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>1 . Known vitamin D deficiency base blood work obtain prior study consent define serum 25hydroxyvitamin D less equal 20 ng/mL within 30 day prior study entry . 2 . Adult , age 18 85 year , male female 3 . If oral vitamin D therapy , stable dose previous 90 day . 1 . History chronic liver disease elevate liver function test , chronic kidney disease ( stage 3 great , eGFR &lt; 60 mL/min ) , uncontrolled thyroid disease ( elevate thyroid function test ) , primary secondary hyperparathyroidism , hypercalcemia , multiple endocrine neoplasia . 2 . Hypercalcemia define either elevate correct serum calcium &gt; 10.2 mg/dL ) measure within 3 month prior study . 3. estimate glomerular filtration rate ( eGFR ) &lt; 60 mL/min within 3 month prior study . 4 . Active cancer 5 . Women pregnant breastfeeding . 6 . Individuals unable give inform consent 7 . Individuals psoriasis , active eczema skin disease , currently receive treatment medication skin disease . 8 . Individuals agree refrain use tan bed duration study . 9 . Individuals agree avoid submerge ointment site water 8 hour ointment application .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>